Centre of Reproductive Medicine and Andrology, Institute of Reproductive and Regenerative Biology, University of Münster, Münster, Germany.
Department of Clinical and Surgical Andrology, Centre of Reproductive Medicine and Andrology, University of Münster, Münster, Germany.
Hum Reprod. 2024 May 2;39(5):892-901. doi: 10.1093/humrep/deae013.
Are there subgroups among patients with cryptozoospermia pointing to distinct etiologies?
We reveal two distinct subgroups of cryptozoospermic (Crypto) patients based on testicular tissue composition, testicular volume, and FSH levels.
Cryptozoospermic patients present with a sperm concentration below 0.1 million/ml. While the etiology of the severely impaired spermatogenesis remains largely unknown, alterations of the spermatogonial compartment have been reported including a reduction of the reserve stem cells in these patients.
STUDY DESIGN, SIZE, DURATION: To assess whether there are distinct subgroups among cryptozoospermic patients, we applied the statistical method of cluster analysis. For this, we retrospectively selected 132 cryptozoospermic patients from a clinical database who underwent a testicular biopsy in the frame of fertility treatment at a university hospital. As controls (Control), we selected 160 patients with obstructive azoospermia and full spermatogenesis. All 292 patients underwent routine evaluation for endocrine, semen, and histological parameters (i.e. the percentage of tubules with elongated spermatids). Moreover, outcome of medically assisted reproduction (MAR) was assessed for cryptozoospermic (n = 73) and Control patients (n = 87), respectively. For in-depth immunohistochemical and histomorphometrical analyses, representative tissue samples from cryptozoospermic (n = 27) and Control patients (n = 12) were selected based on cluster analysis results and histological parameters.
PARTICIPANTS/MATERIALS, SETTING, METHODS: This study included two parts: firstly using clinical parameters of the entire cohort of 292 patients, we performed principal component analysis (PCA) followed by hierarchical clustering on principal components (i.e. considering hormonal values, ejaculate parameters, and histological information). Secondly, for histological analyses seminiferous tubules were categorized according to the most advanced germ cell type present in sections stained with Periodic acid Schif. On the selected cohort of 39 patients (12 Control, 27 cryptozoospermic), we performed immunohistochemistry for spermatogonial markers melanoma-associated antigen 4 (MAGEA4) and piwi like RNA-mediated gene silencing 4 (PIWIL4) followed by quantitative analyses. Moreover, the morphologically defined Adark spermatogonia, which are considered to be the reserve stem cells, were quantified.
The PCA and hierarchical clustering revealed three different clusters, one of them containing all Control samples. The main factors driving the sorting of patients to the clusters were the percentage of tubules with elongated spermatids (Cluster 1, all Control patients and two cryptozoospermic patients), the percentage of tubules with spermatocytes (Cluster 2, cryptozoospermic patients), and tubules showing a Sertoli cells only phenotype (Cluster 3, cryptozoospermic patients). Importantly, the percentage of tubules containing elongated spermatids was comparable between Clusters 2 and 3. Additional differences were higher FSH levels (P < 0.001) and lower testicular volumes (P < 0.001) in Cluster 3 compared to Cluster 2. In the spermatogonial compartment of both cryptozoospermic Clusters, we found lower numbers of MAGEA4+ and Adark spermatogonia but higher proportions of PIWIL4+ spermatogonia, which were significantly correlated with a lower percentage of tubules containing elongated spermatids. In line with this common alteration, the outcome of MAR was comparable between Controls as well as both cryptozoospermic Clusters.
LIMITATIONS, REASONS FOR CAUTION: While we have uncovered the existence of subgroups within the cohort of cryptozoospermic patients, comprehensive genetic analyses remain to be performed to unravel potentially distinct etiologies.
The novel insight that cryptozoospermic patients can be divided into two subgroups will facilitate the strategic search for underlying genetic etiologies. Moreover, the shared alterations of the spermatogonial stem cell compartment between the two cryptozoospermic subgroups could represent a general response mechanism to the reduced output of sperm, which may be associated with a progressive phenotype. This study therefore offers novel approaches towards the understanding of the etiology underlying the reduced sperm formation in cryptozoospermic patients.
STUDY FUNDING/COMPETING INTEREST(S): German research foundation CRU 326 (grants to: SDP, NN). Moreover, we thank the Faculty of Medicine of the University of Münster for the financial support of Lena Charlotte Schülke through the MedK-program. We acknowledge support from the Open Access Publication Fund of the University of Münster. The authors have no potential conflicts of interest.
N/A.
是否存在指向不同病因的隐匿精子症患者亚组?
我们根据睾丸组织成分、睾丸体积和 FSH 水平,揭示了两组截然不同的隐匿精子症(Crypto)患者。
隐匿精子症患者的精子浓度低于 0.100 万/ml。虽然严重受损的精子发生的病因在很大程度上仍然未知,但已经报道了精原细胞室的改变,包括这些患者储备干细胞的减少。
研究设计、大小和持续时间:为了评估隐匿精子症患者中是否存在不同的亚组,我们应用了聚类分析的统计方法。为此,我们从大学医院生育治疗框架下接受睾丸活检的临床数据库中回顾性地选择了 132 名隐匿精子症患者。作为对照(Control),我们选择了 160 名梗阻性无精子症和完全精子发生的患者。所有 292 名患者均接受了内分泌、精液和组织学参数的常规评估(即,具有拉长精子的小管的百分比)。此外,分别评估了隐匿精子症(n=73)和 Control 患者(n=87)的医学辅助生殖(MAR)的结果。为了进行深入的免疫组织化学和组织形态计量学分析,根据聚类分析结果和组织学参数,从隐匿精子症(n=27)和 Control 患者(n=12)中选择了具有代表性的组织样本。
参与者/材料、设置、方法:本研究包括两部分:首先,使用 292 名患者的整个队列的临床参数,我们进行了主成分分析(PCA),然后对主成分进行层次聚类(即考虑激素值、精液参数和组织学信息)。其次,对于组织学分析,根据染色的切片中存在的最先进的生殖细胞类型对生精小管进行分类。在选定的 39 名患者(12 名 Control,27 名隐匿精子症)中,我们进行了黑色素相关抗原 4(MAGEA4)和 piwi 样 RNA 介导的基因沉默 4(PIWIL4)的免疫组织化学检测,并进行了定量分析。此外,还对形态学定义的 Adark 精原细胞进行了定量,这些细胞被认为是储备干细胞。
PCA 和层次聚类显示出三个不同的簇,其中一个簇包含所有 Control 样本。将患者分到簇中的主要因素是具有拉长精子的小管的百分比(簇 1,所有 Control 患者和两名隐匿精子症患者)、具有精母细胞的小管的百分比(簇 2,隐匿精子症患者)和显示出仅支持细胞表型的小管(簇 3,隐匿精子症患者)。重要的是,簇 2 和簇 3 中具有拉长精子的小管的百分比是可比的。其他差异包括 FSH 水平更高(P<0.001)和睾丸体积更小(P<0.001)在簇 3 与簇 2 相比。在两个隐匿精子症簇的精原细胞室中,我们发现 MAGEA4+和 Adark 精原细胞数量较少,但 PIWIL4+精原细胞比例较高,这与具有拉长精子的小管的百分比较低显著相关。与这一共同改变一致,Control 组以及两个隐匿精子症簇的 MAR 结果相当。
局限性、谨慎的原因:虽然我们已经发现隐匿精子症患者队列中存在亚组,但仍需要进行全面的遗传分析,以揭示潜在的不同病因。
隐匿精子症患者可以分为两组的新见解将有助于有针对性地寻找潜在的遗传病因。此外,两个隐匿精子症亚组之间的精原干细胞室的共同改变可能代表对精子输出减少的一般反应机制,这可能与进行性表型相关。因此,本研究为理解隐匿精子症患者精子形成减少的病因提供了新的方法。
研究资金/利益冲突:德国研究基金会 CRU 326(授予:SDP、NN)。此外,我们感谢明斯特大学医学院通过 MedK 计划为 Lena Charlotte Schülke 提供资金支持。我们感谢明斯特大学的开放获取出版基金的支持。作者没有潜在的利益冲突。
无。